Since immune checkpoints can fuel tumor immunotherapy, we also evaluated the correlation of TMEM115 with the common immune checkpoints, the results showed that TMEM115 was correlations with CD274 (PD-L1) (R = 0.15, P = 2.7e-11) (Figures 4B-D). This evidence concerns the gene CD274 and neoplasm.